Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood CellsIris van 't Erve, Jamie E Medina, Alessandro Leal, et al.
Oncotarget|October 27, 2015
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9Jeroen A C M Goos, Veerle M H Coupé, Mark A van de Wiel, et al.
Oncotarget|July 15, 2015
MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patientsKristiaan Lenos, Jeroen A C M Goos, Ilona M Vuist, et al.
International Journal of Cancer|August 15, 2019
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progressionMalgorzata A Komor, Meike de Wit, Jose van den Berg, et al.
The Journal of Liquid Biopsy|September 29, 2025
BLOODPAC's collaborations with European Union liquid biopsy initiativesJennifer Dickey, Elaine Katrivanos, Lauren C Leiman, et al.
JCO Clinical Cancer Informatics|February 11, 2022
Genome Nexus: A Comprehensive Resource for the Annotation and Interpretation of Genomic Variants in CancerIno de Bruijn, Xiang Li, Selcuk Onur Sumer, et al.
The Journal of Molecular Diagnostics : JMD|September 27, 2024
High Prevalence of Chromosomal Rearrangements and LINE Retrotranspositions Detected in Formalin-Fixed, Paraffin-Embedded Colorectal Cancer TissueCarmen Rubio-Alarcón, Ellen Stelloo, Daan C L Vessies, et al.
British Journal of Cancer|November 18, 2016
Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrenceSjoerd H den Uil, Veerle M H Coupé, Janneke F Linnekamp, et al.
Nature Communications|October 21, 2024
Cancer treatment monitoring using cell-free DNA fragmentomesIris van 't Erve, Bahar Alipanahi, Keith Lumbard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2026
plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid TumorsJenna V Canzoniero, Daniel Rabizadeh, Ilias Ziakas, et al.
Pageof 10